AroCell Q1: Unrecognized and going well - Redeye

Redeye makes some minor estimate changes following the report (lowering sales from TUBEX in Africa), but we are encouraged to hear more concrete information about its Chinese partner, ZECEN. Sales came in line, and the gross margin and OPEX were better than expected.

Länk till analysen i sin helhet: https://www.redeye.se/research/1002361/arocell-q1-unrecognized-and-going-well?utm_source=finwire&utm_medium=RSS